Literature DB >> 27008596

Kidneys: key modulators of high-density lipoprotein levels and function.

Haichun Yang1, Agnes B Fogo, Valentina Kon.   

Abstract

PURPOSE OF REVIEW: The review will examine advances in our understanding of the role kidneys play in high-density lipoprotein (HDL) metabolism and the effect on levels, composition, and function of HDL particles. RECENT
FINDINGS: Components of the HDL particles can cross the glomerular filtration barrier. Some of these components, including apolipoproteins and enzymes involved in lipid metabolism, are taken up by the proximal tubule and degraded, modified, salvaged/returned to the circulation, or lost in the urine. Injury of the glomerular capillaries or tubules can affect these intrarenal processes and modify HDL. Changes in the plasma and urine levels of HDL may be novel markers of kidney damage or mechanism(s) of kidney disease.
SUMMARY: The kidneys have a significant role in the metabolism of individual HDL components, which in turn modulate HDL levels, composition, and functionality of HDL particles. These intrarenal effects may be useful markers of kidney damage and have consequences on kidney-related perturbations in HDL.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27008596      PMCID: PMC4899840          DOI: 10.1097/MNH.0000000000000217

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  37 in total

Review 1.  High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis.

Authors:  Wijtske Annema; Arnold von Eckardstein
Journal:  Circ J       Date:  2013-09-20       Impact factor: 2.993

2.  Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats.

Authors:  Yoshikazu Muroya; Osamu Ito; Rong Rong; Kenta Takashima; Daisuke Ito; Pengyu Cao; Yasuhiro Nakamura; Kensuke Joh; Masahiro Kohzuki
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

3.  Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster.

Authors:  L A Woollett; D K Spady
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Cubilin maintains blood levels of HDL and albumin.

Authors:  Obaidullah Aseem; Brian T Smith; Marion A Cooley; Brent A Wilkerson; Kelley M Argraves; Alan T Remaley; W Scott Argraves
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

5.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

6.  Graded effects of proteinuria on HDL structure in nephrotic rats.

Authors:  Gregory C Shearer; John W Newman; Bruce D Hammock; George A Kaysen
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

7.  Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat.

Authors:  John W Newman; George A Kaysen; Bruce D Hammock; Gregory C Shearer
Journal:  J Lipid Res       Date:  2007-05-11       Impact factor: 5.922

8.  Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study.

Authors:  Michelle C Odden; Ira B Tager; Ron T Gansevoort; Stephan J L Bakker; Linda F Fried; Anne B Newman; Ronit Katz; Suzanne Satterfield; Tamara B Harris; Mark J Sarnak; David Siscovick; Michael G Shlipak
Journal:  Ann Epidemiol       Date:  2013-01-10       Impact factor: 3.797

9.  Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.

Authors:  Michal Herman-Edelstein; Pnina Scherzer; Ana Tobar; Moshe Levi; Uzi Gafter
Journal:  J Lipid Res       Date:  2013-12-26       Impact factor: 5.922

10.  Arginine-directed glycation and decreased HDL plasma concentration and functionality.

Authors:  L Godfrey; N Yamada-Fowler; J Smith; P J Thornalley; N Rabbani
Journal:  Nutr Diabetes       Date:  2014-09-01       Impact factor: 5.097

View more
  12 in total

1.  Urinary apolipoprotein AI in children with kidney disease.

Authors:  Amanda J Clark; Kathy Jabs; Tracy E Hunley; Deborah P Jones; Rene G VanDeVoorde; Carl Anderson; Liping Du; Jianyong Zhong; Agnes B Fogo; Haichun Yang; Valentina Kon
Journal:  Pediatr Nephrol       Date:  2019-06-23       Impact factor: 3.714

Review 2.  HDL in CKD-The Devil Is in the Detail.

Authors:  Florian Kronenberg
Journal:  J Am Soc Nephrol       Date:  2018-02-22       Impact factor: 10.121

3.  HDL and Kidney Diseases.

Authors:  Huanhuan Cao; Xia Meng
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  The Roles of Fatty Acids and Apolipoproteins in the Kidneys.

Authors:  Xiaoyue Pan
Journal:  Metabolites       Date:  2022-05-20

5.  APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study.

Authors:  Ninad S Chaudhary; Hemant K Tiwari; Bertha A Hidalgo; Nita A Limdi; Richard J Reynolds; Mary Cushman; Neil A Zakai; Leslie Lange; Suzanne E Judd; Cheryl A Winkler; Jeffrey B Kopp; Orlando M Gutiérrez; Marguerite R Irvin
Journal:  Am J Nephrol       Date:  2022-01-31       Impact factor: 4.605

6.  CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsis.

Authors:  Kelly Roveran Genga; Mark Trinder; HyeJin Julia Kong; Xuan Li; Alex K K Leung; Tadanaga Shimada; Keith R Walley; James A Russell; Gordon A Francis; Liam R Brunham; John H Boyd
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

7.  Association of acute Babesia canis infection and serum lipid, lipoprotein, and apoprotein concentrations in dogs.

Authors:  Zorana Milanović; Jelena Vekić; Vladimir Radonjić; Anja Ilić Božović; Aleksandra Zeljković; Jelena Janac; Vesna Spasojević-Kalimanovska; Jesse Buch; Ramaswamy Chandrashekar; Žanka Bojić-Trbojević; Ljiljana Hajduković; Mary M Christopher; Milica Kovačević Filipović
Journal:  J Vet Intern Med       Date:  2019-06-07       Impact factor: 3.333

8.  A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental Glomerulosclerosis.

Authors:  Conxita Jacobs-Cachá; Natàlia Puig-Gay; Dominic Helm; Mandy Rettel; Joana Sellarès; Anna Meseguer; Mikhail M Savitski; Francesc J Moreso; Maria José Soler; Daniel Seron; Joan Lopez-Hellin
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

9.  Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Julio A Lamprea-Montealegre; Robyn L McClelland; James D Otvos; Samia Mora; Manja Koch; Majken K Jensen; Ian H de Boer
Journal:  J Am Heart Assoc       Date:  2019-12-10       Impact factor: 5.501

10.  Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys.

Authors:  Natalya A Blessing; Zhenzhen Wu; Sethu M Madhavan; Jonathan W Choy; Michelle Chen; Myung K Shin; Maarten Hoek; John R Sedor; John F O'Toole; Leslie A Bruggeman
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.